Search results for: 'cell ad g01e therapeutics market'

Therapeutic medical devices play a significant role in the long-term treatment of chronic conditions such as cancer and neurological diseases. Non-invasive therapeutic medical devices capable of offering home-based treatment provide high patient comfort and adherence to the prescribed therapy. With the changing preference of the patients, the medic...

The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2...

The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...

This research service explores the market for therapeutics used for the treatment of breast cancer in the Unites States of America. It analyzes the various challenges faced by pharmaceutical companies, and the competitive advantages and disadvantages of their products in the market.

This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the rheumatoid arthritis therapeutics market in Thailand.

This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the rheumatoid arthritis therapeutics market in India.

This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the rheumatoid arthritis therapeutics market in the Philippines.

09 Nov 2022  |  Global  |  Technology Research

Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis

Strategic partnering and new product development will enable better biologics for personalized and targeted treatment

Infographics

×

Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...